Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia

American Journal of Medical Genetics, Part A

Volumn 140 A, Issue 7, 2006, Pages 678-684

  Bellini, Carlo ^a,d   Hennekam, Raoul C M ^b,c   Boccardo, Francesco ^d   Campisi, Corradino ^d   Serra, Giovanni ^a   Bonioli, Eugenio ^d  

^a G GASLINI INSTITUTE   (Italy)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Congenital lymphatic dysplasia; Nonimmune idiopathic hydrops fetalis

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL LYMPHATIC DYSPLASIA; CONGENITAL LYMPHATIC SYSTEM DISORDER; FETUS HYDROPS; HUMAN; IDIOPATHIC DISEASE; LYMPHOSCINTIGRAPHY; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; CASE REPORT; CONGENITAL MALFORMATION; INFANT; LYMPH VESSEL; LYMPHATIC SYSTEM; MULTIPLE MALFORMATION SYNDROME; PATHOLOGY;

ABNORMALITIES, MULTIPLE; HUMANS; HYDROPS FETALIS; INFANT; INFANT, NEWBORN; LYMPHATIC SYSTEM; LYMPHATIC VESSELS;

EID: 33646943345     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31100     Document Type: Article

References (28)

1. Anandakumar C, Biswas A, Wong YC, Chia D, Annapoorna V, Arulkumaran S, Ratnam S. 1996. Management of non-immune hydrops: 8 years' experience. Ultrasound Obstet Gynecol 8:196-200.
2. Bellini C, Arioni C, Mazzella M, Campisi C, Taddei G, Boccardo F, Serra G. 2002. Lymphoscintigraphic evaluation of congenital lymphedema of the newborn. Clin Nucl Med 27:383-384.
3. Bellini C, Mazzella M, Arioni C, Campisi C, Taddei G, Toma P, Boccardo F, Hennekam RC, Serra G. 2003. Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet Part A 120A:92-96.
4. Bellini C, Mazzella M, Campisi C, Taddei G, Mosca F, Toma P, Villa G, Boccardo F, Sementa AR, Hennekam RC, et al. 2004. Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology 37:22-30.
5. Bellini C, Boccardo F, Taddei G, Mazzella M, Arioni C, Hennekam RC, Serra G, Campisi C. 2005. Diagnostic protocol for lymphoscintigraphy in newborns. Lymphology 38:9-15.
6. Brace OA. 2004. Fluid distribution in the fetus and neonate. In: Polin RA, Fox WW, Abam SH, editors. Fetal and neonatal physiology. 2nd edition. Philadelphia: Saunders. pp 1341-1364.
7. Bukowski R, Saade GR. 2000. Hydrops fetalis. Clin Perinatol 27:1007-1031.
8. Burin MG, Scholz AP, Gus R, Sanseverino MT, Fritsh A, Magalhaes JA, Timm F, Barrios P, Chesky M, Coelho JC, et al. 2004. Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn 24:653-657.
9. Carlson DE, Platt LD, Medearis AL, Horenstein J. 1990. Prognostic indicators of the resolution of nonimmune hydrops fetalis and survival of the fetus. Am J Obstet Gynecol 163:1785-1787.
10. Favre R, Dreux S, Dommergues M, Dumez Y, Luton D, Oury JF, Fiblec BL, Nisand I, Muller F. 2004. Nonimmune fetal ascites: A series of 79 cases. Am J Obstet Gynecol 190:407-412.
11. Heinonen S, Ryynanen M, Kirkinen P. 2000. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand 79:15-18.
12. Hennekam RC. 2000. Syndromic Lymphatic Maldevelopment. In: Witte M, editor. Conquering Lymphatic Disease - NIH Think Tank Conference; May 11-13; Bethesda, Maryland, USA: University of Arizona pub. p 70-73.
13. Irons MB, Bianchi DW, Geggel RL, Marx GR, Bhan I. 1996. Possible new autosomal recessive syndrome of lymphedema, hydroceles, atrial septal defect, and characteristic facial changes. Am J Med Genet 66:69-71.
14. Iskaros J, Jauniaux E, Rodeck C. 1997. Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol 90:321-325.
15. Jacquemont S, Barbarot S, Boceno M, Stalder JF, David A. 2000. Familial congenital pulmonary lymphangectasia, nonimmune hydrops fetalis, facial and lower limb lymphedema: Confirmation of Njolstad's report. Am J Med Genet 93:264-268.
16. Machin GA. 1989. Hydrops revisited: Literature review of 1,414 cases published in the 1980s. Am J Med Genet 34:366-390.
17. Mascaretti RS, Falcao MC, Silva AM, Vaz FA, Leone CR. 2003. Characterization of newborns with nonimmune hydrops fetalis admitted to a neonatal intensive care unit. Rev Hosp Clin Fac Med Sao Paulo 58:125-132.
18. McCoy MC, Katz VL, Gould N, Kuller JA. 1995. Non-immune hydrops after 20 weeks' gestation: Review of 10 years' experience with suggestions for management. Obstet Gynecol 85:578-582.
19. Moerman P, Vandenberghe K, Devlieger H, Van Hole C, Fryns JP, Lauweryns JM. 1993. Congenital pulmonary lymphangiectasis with chylothorax: A heterogeneous lymphatic vessel abnormality. Am J Med Genet 47:54-58.
20. Njolstad PR, Reigstad H, Westby J, Espeland A. 1998. Familial non-immune hydrops fetalis and congenital pulmonary lymphangiectasia. Eur J Pediatr 157:498-501.
21. Northup KA, Witte MH, Witte CL. 2003. Syndromic classification of hereditary lymphedema. Lymphology 36:162-189.
22. Poeschmann RP, Verheijen RH, Van Dongen PW. 1991. Differential diagnosis and causes of nonimmunological hydrops fetalis: A review. Obstet Gynecol Surv 46:223-231.
23. Potter EL. 1943. Universal edema of the fetus unassociated with erythroblastosis. Am J Obstet Gynecol 51:885.
24. Scott-Emuakpor AB, Warren ST, Kapur S, Quiachon EB, Higgins JV. 1981. Familial occurrence of congenital pulmonary lymphangiectasis. Genetic implications. Am J Dis Child 135:532-534.
25. Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. 1980. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700-704.
26. Swain S, Cameron AD, McNay MB, Howatson AG. 1999. Prenatal diagnosis and management of nonimmune hydrops fetalis. Aust N Z J Obstet Gynaecol 39:285-290.
27. van Straaten HL, Gerards LJ, Krediet TG. 1993. Chylothorax in the neonatal period. Eur J Pediatr 152:2-5.
28. Wieacker P, Muschke P, Pollak KH, Muller R. 2005. Autosomal recessive non-immune hydrops fetalis caused by systemic lymphangiectasia. Am J Med Genet Part A 132A:318-319.